Litcius/Paper detail

Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice

Ahmed Nadeem, Sheikh F. Ahmad, Naif O. Al‐Harbi, Khalid E. Ibrahim, Faleh Alqahtani, Homood M. As Sobeai, Moureq R. Alotaibi

2020Biochimie46 citationsDOI

Topics & Concepts

FOXP3InflammationPsoriasisImmunologyImmune systemSTAT3T cellImiquimodInterleukin 23Tumor necrosis factor alphaMedicineInterleukin 17Cancer researchSignal transductionBiologyCell biologyPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesT-cell and B-cell Immunology
Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice | Litcius